(Q38034387)

27 August 2017

Gene expression profiling in human neurodegenerative disease (English)

1 reference

27 August 2017

1 reference

Johnathan Cooper-Knock

Johnathan Cooper-Knock

1

0 references

Laura Ferraiuolo

Laura Ferraiuolo

3

0 references

Janine Kirby

Janine Kirby

2

0 references

Magnus Rattray

Magnus Rattray

5

0 references

Pamela Shaw

Pamela J Shaw

6

0 references

author name string

Paul R Heath

4

1 reference

PubMed ID

22890216

27 August 2017

language of work or name

English

0 references

publication date

14 August 2012

1 reference

27 August 2017

Nature Reviews Neurology

1 reference

27 August 2017

8

1 reference

27 August 2017

518-530

1 reference

27 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2012.156

27 August 2017

0 references

cites work

Quantitative monitoring of gene expression patterns with a complementary DNA microarray

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Sporadic ALS has compartment-specific aberrant exon splicing and altered cell-matrix adhesion biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Novel FUS/TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Broad clinical phenotypes associated with TAR-DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Microarray analysis of peripheral blood lymphocytes from ALS patients and the SAFE detection of the KEGG ALS pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Differential gene expression in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Molecular markers of early Parkinson's disease based on gene expression in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Multiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Transcriptional changes in multiple system atrophy and Parkinson's disease putamen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Mitochondrial abnormalities in the putamen in Parkinson's disease dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Microarray expression analysis in idiopathic and LRRK2-associated Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Targeting programmed cell death in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Molecular Pathways of Neurodegeneration in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

The 1.6-A crystal structure of the class of chaperones represented by Escherichia coli Hsp31 reveals a putative catalytic triad

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Analysis of alpha-synuclein, dopamine and parkin pathways in neuropathologically confirmed parkinsonian nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Effects of gender on nigral gene expression and parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Neuronal gene expression correlates of Parkinson's disease with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Calcium, ageing, and neuronal vulnerability in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Variance of gene expression identifies altered network constraints in neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Disease-specific, neurosphere-derived cells as models for brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Inflammatory changes parallel the early stages of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Autotaxin expression is enhanced in frontal cortex of Alzheimer-type dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Comprehensive mRNA expression profiling distinguishes tauopathies and identifies shared molecular pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Gene expression signature is shared by patients with Alzheimer's disease and schizophrenia at the superior temporal gyrus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Analysis of alternative splicing associated with aging and neurodegeneration in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Gene expression changes in the course of normal brain aging are sexually dimorphic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Local gene expression in axons and nerve endings: the glia-neuron unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Gene expression correlates of neurofibrillary tangles in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Analysis of Alzheimer's disease severity across brain regions by topological analysis of gene co-expression networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Commonalities between genetics of cardiovascular disease and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer's pathology and APOE genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Transcriptional profiling of Alzheimer blood mononuclear cells by microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

A unique gene expression signature discriminates familial Alzheimer's disease mutation carriers from their wild-type siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Gene expression profile analysis of lymphocytes from Alzheimer's patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Loss of apolipoprotein E receptor LR11 in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Understanding the pathogenesis of Alzheimer's disease: will RNA-Seq realize the promise of transcriptomics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

A cross-study transcriptional analysis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Optimisation of postmortem tissue preservation and alternative protocol for serotonin transporter gene polymorphisms amplification in SIDS and SIUD cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Effects of antemortem and postmortem variables on human brain mRNA quality: a BrainNet Europe study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

RNA quality in frozen breast cancer samples and the influence on gene expression analysis--a comparison of three evaluation methods using microcapillary electrophoresis traces

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

The RIN: an RNA integrity number for assigning integrity values to RNA measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Impact of RNA degradation on gene expression profiles: assessment of different methods to reliably determine RNA quality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Evaluation of gene expression measurements from commercial microarray platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Biological assessment of robust noise models in microarray data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

The optimal discovery procedure for large-scale significance testing, with applications to comparative microarray experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Identifying biological themes within lists of genes with EASE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Probe-level measurement error improves accuracy in detecting differential gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Current-generation high-throughput sequencing: deepening insights into mammalian transcriptomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Alternative pre-mRNA splicing switches modulate gene expression in late erythropoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Mapping and quantifying mammalian transcriptomes by RNA-Seq

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Sequencing technologies - the next generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Characterization and improvement of RNA-Seq precision in quantitative transcript expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

A genetic signature can predict prognosis and response to therapy in breast cancer: Oncotype DX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Outcome signature genes in breast cancer: is there a unique set?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Cell death in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Commonalities in the genetics of Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Muscle gene expression is a marker of amyotrophic lateral sclerosis severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Kalirin is under-expressed in Alzheimer's disease hippocampus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Gene expression profiling in Alzheimer's disease brain microvessels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

A gene expression pattern in blood for the early detection of Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

A novel blood test for the early detection of Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Whole-transcriptome RNAseq analysis from minute amount of total RNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.156

Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22890216

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22890216

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22890216

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEUROL.2012.156

1 reference

PubMed ID

22890216

Dimensions Publication ID

27 August 2017

0 references

1 reference

PubMed ID

22890216